Drug intelligence / Profile preview

Isovue

Development stage
Unknown
Lead developer
Bracco Diagnostics
Modality
Small Molecules
Administration
Intravenous, Intra-arterial, Intrathecal
01

Overview

Isovue (iopamidol injection) is a nonionic, low-osmolar iodinated contrast agent developed and manufactured by Bracco Diagnostics. As a small molecule radiographic contrast medium, it is used to enhance the visualization of internal structures during diagnostic imaging procedures, including computed tomography (CT) and various forms of arteriography. The drug functions by increasing the attenuation of X-rays due to the presence of iodine atoms in the iopamidol molecule, thereby providing radiopaque contrast in blood vessels, organs, and tissues. It is FDA-approved for both intravenous and intra-arterial administration and has been extensively studied in specific patient populations, such as those with renal impairment undergoing imaging for conditions like liver disease or peripheral arterial disease.

Brand names
IsovueIsovue-MIsovue-200Isovue200Isovue 200Isovue-250Isovue250Isovue 250Isovue-300Isovue300Isovue 300Isovue-370Isovue370Isovue 370
Other names
iopamidoliopamidol injection

Beyond the preview

Go deeper on Isovue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Isovue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call